ZA974785B - Growth hormone and estrogen in the treatment of osteoporosis. - Google Patents
Growth hormone and estrogen in the treatment of osteoporosis.Info
- Publication number
- ZA974785B ZA974785B ZA9704785A ZA974785A ZA974785B ZA 974785 B ZA974785 B ZA 974785B ZA 9704785 A ZA9704785 A ZA 9704785A ZA 974785 A ZA974785 A ZA 974785A ZA 974785 B ZA974785 B ZA 974785B
- Authority
- ZA
- South Africa
- Prior art keywords
- estrogen
- osteoporosis
- treatment
- growth hormone
- hormone
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 208000001132 Osteoporosis Diseases 0.000 title 1
- 229940011871 estrogen Drugs 0.000 title 1
- 239000000262 estrogen Substances 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK62396 | 1996-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA974785B true ZA974785B (en) | 1998-01-22 |
Family
ID=8095682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9704785A ZA974785B (en) | 1996-05-31 | 1997-05-30 | Growth hormone and estrogen in the treatment of osteoporosis. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0907374A1 (xx) |
JP (1) | JP2000512274A (xx) |
KR (1) | KR20000016204A (xx) |
CN (1) | CN1220609A (xx) |
AU (1) | AU3025997A (xx) |
BR (1) | BR9709499A (xx) |
CA (1) | CA2257174A1 (xx) |
CZ (1) | CZ383298A3 (xx) |
HU (1) | HUP9904049A3 (xx) |
IL (1) | IL126983A0 (xx) |
NO (1) | NO985573L (xx) |
PL (1) | PL330239A1 (xx) |
WO (1) | WO1997046252A1 (xx) |
ZA (1) | ZA974785B (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HN1996000101A (es) | 1996-02-28 | 1997-06-26 | Inc Pfizer | Terapia combinada para la osteoporosis |
GB2324726A (en) * | 1997-05-01 | 1998-11-04 | Merck & Co Inc | Combination Therapy for the Treatment of Osteoporosis |
JP4574849B2 (ja) * | 1998-06-09 | 2010-11-04 | サファイア セラピューティクス,インコーポレイティド | 成長ホルモン放出特性を有する化合物を調製するための方法 |
US6784158B1 (en) | 1998-06-09 | 2004-08-31 | Novo Nordisk A/S | Method for preparing a compound with growth hormone releasing properties |
JP2001031635A (ja) * | 1999-07-14 | 2001-02-06 | Ajinomoto Co Inc | 光学活性n−保護−n−メチル−フェニルアラニン誘導体の製造方法 |
EP1159964B1 (en) | 2000-05-31 | 2009-10-28 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating gastrointestinal motility |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
ES2604943T3 (es) | 2007-02-09 | 2017-03-10 | Ocera Therapeutics, Inc. | Moduladores macrocíclicos del receptor de la grelina y procedimientos de uso de los mismos |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ236618A (en) * | 1990-01-03 | 1997-06-24 | Ciba Geigy Ag | Treating and preventing osteoporosis using insulin-like growth factor i (igf i) in conjunction with a bone antiresorptive active compound |
ES2099245T3 (es) * | 1990-11-26 | 1997-05-16 | Robert R Recker | Tratamiento de la osteoporosis usando factor de liberacion de hormona de crecimiento (grf) en combinacion con hormona paratiroidea (pth). |
BR9407869A (pt) * | 1993-10-19 | 1996-10-29 | Merck & Co Inc | Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose |
-
1997
- 1997-05-29 BR BR9709499A patent/BR9709499A/pt not_active Application Discontinuation
- 1997-05-29 CN CN97195144A patent/CN1220609A/zh active Pending
- 1997-05-29 CA CA002257174A patent/CA2257174A1/en not_active Abandoned
- 1997-05-29 HU HU9904049A patent/HUP9904049A3/hu unknown
- 1997-05-29 PL PL97330239A patent/PL330239A1/xx unknown
- 1997-05-29 KR KR1019980709772A patent/KR20000016204A/ko not_active Application Discontinuation
- 1997-05-29 EP EP97924934A patent/EP0907374A1/en not_active Withdrawn
- 1997-05-29 AU AU30259/97A patent/AU3025997A/en not_active Abandoned
- 1997-05-29 WO PCT/DK1997/000239 patent/WO1997046252A1/en not_active Application Discontinuation
- 1997-05-29 JP JP10500108A patent/JP2000512274A/ja active Pending
- 1997-05-29 CZ CZ983832A patent/CZ383298A3/cs unknown
- 1997-05-29 IL IL12698397A patent/IL126983A0/xx unknown
- 1997-05-30 ZA ZA9704785A patent/ZA974785B/xx unknown
-
1998
- 1998-11-27 NO NO985573A patent/NO985573L/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO985573D0 (no) | 1998-11-27 |
IL126983A0 (en) | 1999-09-22 |
PL330239A1 (en) | 1999-05-10 |
KR20000016204A (ko) | 2000-03-25 |
BR9709499A (pt) | 1999-08-10 |
HUP9904049A3 (en) | 2000-07-28 |
AU3025997A (en) | 1998-01-05 |
HUP9904049A2 (hu) | 2000-04-28 |
CN1220609A (zh) | 1999-06-23 |
JP2000512274A (ja) | 2000-09-19 |
WO1997046252A1 (en) | 1997-12-11 |
EP0907374A1 (en) | 1999-04-14 |
CZ383298A3 (cs) | 1999-07-14 |
CA2257174A1 (en) | 1997-12-11 |
NO985573L (no) | 1999-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5176898A (en) | Integrated bone cement mixing and dispensing system | |
EP0741578A4 (en) | HUMAN GROWTH HORMONE | |
AU3218197A (en) | Natural progesterone for the treatment of side effects of progestins and progesterone analogues | |
ZA987385B (en) | Growth hormone secretagogues. | |
GB2319912B (en) | Oscillator and method for controlling the same | |
ZA979011B (en) | Hormonal composition and its use. | |
ZA974785B (en) | Growth hormone and estrogen in the treatment of osteoporosis. | |
EP0890599A4 (en) | POLYORGANOSILOXANES AND METHOD FOR THE PRODUCTION THEREOF | |
HUP9904175A3 (en) | Human growth gene and short stature gene region | |
IL115224A0 (en) | Preparations for use in the treatment of osteoporosis | |
GB9616700D0 (en) | Hormone supplement | |
ZA9711148B (en) | Bone stimulating factor. | |
IL120265A0 (en) | Combination therapy to treat osteoporosis - polyphosphonates or progestins and estrogen agonists | |
ZA9711047B (en) | Formulation and use. | |
IL120263A0 (en) | Combination therapy to prevent bone loss-progesterone and estrogen agonists | |
AUPO350296A0 (en) | Mixing and transporting device | |
IL134282A0 (en) | Inhibition of unwanted hormone action in plants | |
GB9609944D0 (en) | An improvement in the treatment of wastes | |
PL331283A1 (en) | Preparation for treating and/or preventing stupefaction | |
EP1032266A4 (en) | USE OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION IN THE TREATMENT OF ARTHRITIS | |
GB2309559B (en) | Microprocessor and system | |
SI0935469T1 (en) | Use of growth hormone | |
GB9707299D0 (en) | Hormone treatment | |
GB9803693D0 (en) | Hormone treatment | |
NZ328739A (en) | Treatment of estrogen therapy using 8,9-dehydroesterone |